Prevalence and factors associated with cutaneous manifestations of type 2 diabetes mellitus

被引:0
作者
Rasid, Saadah [1 ]
Muthupalaniappen, Leelavathi [1 ]
Jamil, Adawiyah [1 ]
机构
[1] Pusat Perubatan Univ Kebangsaan Malaysia, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
来源
CLINICAL DIABETOLOGY | 2020年 / 9卷 / 06期
关键词
diabetes mellitus; skin manifestations; glycated hemoglobin A; prevalence; SKIN;
D O I
10.5603/DK.2020.0049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Type 2 diabetes mellitus (T2DM) is known to cause multiple systemic manifestations. However, there are limited studies describing cutaneous manifestation among T2DM in Malaysia. The objective of this study was to determine the prevalence of cutaneous manifestation among T2DM patients, types of lesions and its associated factors. Methods. A cross-sectional study was conducted among 271 T2DM patients at a primary care clinic in Kuala Lumpur. Results. More than one third (63.5%) of patients were found to have cutaneous manifestations of T2DM. The most common manifestation was infections (34.7%) followed by Skin Diseases with Weak to Strong Association with Diabetes (SDWSAD) (31.7%), Skin Manifestation of Diabetic Complication (SMDC) (2.2%) and others cutaneous lesions (22.1%). Among the infections, onychomycosis was the commonest type of infection (27.7%) while diabetic dermopathy was the commonest lesion of SDWSAD (29.7%). Males had almost two times the odds of developing cutaneous manifestations of T2DM, compared to females (adjusted odds ratio [AOR]: 1.871, 95% CI: 1.108-3.160; P = 0.019). There was no association between glycemic control and cutaneous manifestations. However, males and those with T2DM duration of five years and more had 2.6 times the odds of developing SDWSAD (AOR: 2.646, 95% CI: 1.506-4.648 P = 0.001) and (AOR: 2.635, 95% CI: 1.107-6.268, P = 0.028) respectively. Those with diabetic neuropathy and peripheral vascular disease (PVD) had very high odds of developing SMDC such as diabetic foot and trophic ulcers (AOR: 23.259, 95% CI: 1.191-454.2, P = 0.038) and (AOR: 102.36, 95% CI: 4.013-2610, P = 0.005), respectively. Conclusion. The knowledge of these cutaneous manifestations increases physician's awareness and prompts early screening to reduce morbidity improve quality of life.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 28 条
  • [1] Ab Rahman NK, 2016, MALAYSIAN J PUBLIC H, V16, P41
  • [2] Azmi, 2013, MINIST HLTH MALAYS, V1, P2009
  • [3] Skin signs in diabetes mellitus
    Behm, B.
    Schreml, S.
    Landthaler, M.
    Babilas, P.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (10) : 1203 - 1211
  • [4] Bhat YJ., 2006, INT J DIAB DEV CTRIE, V26, P152, DOI DOI 10.4103/0973-3930.33180
  • [5] Bustan RS, 2017, DAN MED J, V64
  • [6] Callen J.P., 2016, Dermatological Signs of Systemic Disease E-Book
  • [7] Skin disorders in diabetes mellitus: an epidemiology and physiopathology review
    Campos de Macedo, Geisa Maria
    Nunes, Samanta
    Barreto, Tania
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2016, 8
  • [8] Metabolic syndrome associated with toenail onychomycosis in Taiwanese with diabetes mellitus
    Chang, Shun-Jen
    Hsu, Shih-Chieh
    Tien, Kai-Jen
    Hsiao, Jeng-Yueh
    Lin, Shiu-Ru
    Chen, Hung-Chun
    Hsieh, Ming-Chia
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (05) : 467 - 472
  • [9] Chatterjee Nandini, 2014, Indian J Endocrinol Metab, V18, P217, DOI 10.4103/2230-8210.129115
  • [10] A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
    Crawford, Fay
    Cezard, Genevieve
    Chappell, Francesca M.
    Murray, Gordon D.
    Price, Jacqueline F.
    Sheikh, Aziz
    Simpson, Colin R.
    Stansby, Gerard P.
    Young, Matthew J.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (57) : 1 - +